CD8A and neoplasm: Knockdown Nrp1 in CD8+ T cells1. Evaluated the anti-tumor effects of Knockdown Nrp1 in CD8+ T cells;2. Increased the frequency of Tpex and memory T cells in TME;3. Exhibited greater effector function upon re-stimulation and promoted long-term immunity;